Navigation Links
LSUHSC faculty shares inside knowledge in book to develop nation's research scientists
Date:11/19/2013

ntors are nave of what is required to construct the best training grant they can possibly put together, as I was myself, and as such have grants returned to them, having not been discussed," says Dr. Hollenbach. "The more I saw this happening, the more I realized that I had a unique position from my repeat presence on study section to assist trainees and help them understand the extent of information needed for the application, the purpose of every component of the application, and provide insight into exactly what the reviewers are looking for and the biases and prejudices that exist in the reviewing process."

Dr. Hollenbach, who now holds three patents, continues to conduct basic research on biological mechanisms resulting in the development of cancer, particularly the childhood solid muscle tumor alveolar rhabdomyosarcoma (ARMS) and melanoma. He also continues to teach and mentor health professions students at LSU Health Sciences Center New Orleans and to serve as an ad hoc reviewer of national and international research journals.

A Practical Guide to Writing a Ruth L. Kirschstein NRSA Grant by Andrew D. Hollenbach is available at the Elsevier Store, Amazon.com, eBay, and a number of other booksellers.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
594-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. LSUHSCs Rodriguez receives cancer immunotherapy Presidential Award
2. Polish Academy Of Sciences awards LSUHSCs Bazan Medal
3. LSUHSC simulation or team training improves performance & patient safety
4. LSUHSC simulation or team training improves performance & patient safety
5. LSUHSC bird study finds key info about human speech-language development
6. LSUHSC study reports racial/ethnic differences in young people with cancer
7. LA Tumor Registry at LSUHSC receives $1.3 million from NCI
8. LSUHSC Dental School awarded $1.8 million for HIV care and education
9. LSUHSC research adds new info to improve pediatric dental sedation
10. LSUHSCs Hollier one of few ever awarded coveted national lectureship
11. LSUHSC paper judged best of the year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... ... From Aug. 17-21, Calvary Hospital hosted the 18th consecutive session of its bereavement ... place at Kingsborough Community College in Brooklyn in each of the past three years. ... two junior counselors who were campers themselves just a few years ago. , The ...
(Date:9/1/2015)... ... September 01, 2015 , ... Horizon Blue Cross Blue Shield of New Jersey ... in the LATINA Style 50 Report that recognizes companies that provide the best career ... Horizon BCBSNJ climbs from number 24 to 21 of the 50 Best Companies for ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... prevent different malignancies. Some options for cancer treatment are available belonging to ... distinctive approach is necessary for effective treatment. Several molecules have been discovered ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... delivery options, Blue Cross and Blue Shield of Minnesota (Blue Cross) has announced ... , Based in San Francisco, Doctor On Demand provides immediate access to ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... creates negative pressure inside a wound to remove exudates, fluid, and infectious materials ... (comprising portable devices, stand-alone devices, disposable devices, and canisters, etc.) is projected to ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3
... new study it was found that researchers at the UC ... amino acids // . The speciality of this discovery is ... and specificity towards leukemic and lymphoma cells. Hence researchers say ... deliver anti-cancer drugs. ,The study results were published ...
... nonepileptic seizures, or psychogenic seizures are often misdiagnosed as ... //whereas epilepsy is caused by the abnormal electrical activity ... seizures are similar to epileptic seizures, they can be ... June 13, 2006, issue of Neurology, the scientific journal ...
... that a short course of a drug could relieve severe ... million youngsters in mainly poor countries each year. ... Romark Laboratories under the brand name Alinia, had been found ... in young children with a severe form of the illness. ...
... to completely avoid consuming Vitamin E supplements, as this is ... ,A leading obstetrician, Prof Stuart Campbell, has appealed to ... following clinical trials that have revealed that this vitamin can ... known to increase the rates of still births and cause ...
... news agency reports, northern Ukraine faces the initial attack of ... destroy domestic poultry //. ,In southern Ukraine, ... peninsula, firstly diagnosed a case of avian flu in last ... to villagers and done so by the Ukraine's Emergencies Ministry, ...
... scientists have claimed that they have identified three new cataract-causing ... in families in India. ,Scientists from the Center ... with researchers from the National Institute of Health, USA and ... 30 years of research in the field of ophthalmology, to ...
Cached Medicine News:Health News:New Molecular Treatment Identified To Treat Blood Cell Cancers 2Health News:Clues To Identify Psychological Seizures 2Health News:Clues To Identify Psychological Seizures 3Health News:Indian Scientists Identify Cataract Causing Genes 2
(Date:9/1/2015)... , Sept. 1, 2015  AccuTec Blades, Inc. today ... Industrial Blades division.  EPC announced in May 2015 its ... Verona, Virginia and Obregon, ... the sale process. Rick Gagliano ... AccuTec Blades said, "Our new name, AccuTec Blades, reflects ...
(Date:9/1/2015)... , Sept. 1, 2015 Nevro Corp. ... that is providing innovative evidence-based solutions for the treatment ... submitted its preliminary response to the Patent Trial and ... inter partes review (IPR), filed by a unit ... claims in U.S. Patent No. 8,359,102 (the ,102 patent). The ...
(Date:9/1/2015)... YEHUDA, Israel , Sept. 1, 2015 ... ), a leading innovator of less invasive, miniaturized circulatory ... heart failure, announced today that it has entered into ... . ("Valtech").  Valtech is a privately held company that ... valve repair and replacement devices for the treatment of ...
Breaking Medicine Technology:AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 4HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 5HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 6HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 7HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 8HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 9HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 10
... March 30, 2011 Regado Biosciences, a privately held ... control agents, announced that David J. Mazzo, PhD, President ... Company,s 10th Annual Healthcare Conference at the New York ... 6, 2011 at 11:20 a.m. EDT.  The presentation will ...
... Inc. (Nasdaq: ABAX ), a medical products company ... chairman and chief executive officer,  will present at the 10th ... 8:40 a.m. ET. The conference will be held at the ... About Abaxis Abaxis develops, manufactures and markets portable blood ...
Cached Medicine Technology:Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City 2Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City 3
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
Cruciate retaining, posterior stabilized and constrained components....
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
...
Medicine Products: